New Novartis drug shows potential in heart failure treatment Reuters LCZ696 reduces protein linked to heart failure in study. * Targets type of heart failure where other options lacking. * Novartis aims to revive heart portfolio as Diovan declines. By Ben Hirschler. MUNICH, Aug 26 (Reuters) - An experimental drug from ... |
